3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
37
Neoplasm Metastasis
2
Breast Diseases
2
Luminal B/HER2-negative Breast Cancer
1
Hormone Receptor Positive Breast Carcinoma
1
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
1
HR+/HER2- Early Breast Cancer
1
HR+/HER2+ Early Breast Cancer
1
Estrogen Receptor and/or Progesterone Receptor Positive
1
Endometrial Stromal Tumors
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms, Male
1
Breast Cancer Female
1
Arthralgia
1
Advanced Breast Cancer
1
Interventions
Therapeutics
1
Testosterone
1
Surveys and Questionnaires
1
Letrozole
1
Hyaluronic Acid
1
Glucosamine
1
Glucaric Acid
1
Chondroitin Sulfates
1
Chondroitin
1
Cholecalciferol
1
Cannabidiol
1
Calcium Gluconate
1
Calcium Citrate
1
Calcium Carbonate
1
Calcium
1
Aromatase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Arthralgia
×
Aromatase Inhibitors
×
Clear all
NCT01612728
2013-02-12
AIA
Baylor Breast Care Center
Phase 2
Withdrawn